Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084290 · ClinicalTrials.gov registry record · NA
Evaluating a Shared Decision Making Program for Crohn's Disease
A NA study of Crohn's Disease, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 14
- Study locations
NCT02084290: Completed NA study of Crohn's Disease, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02084290 is a NA study of Crohn's Disease that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 204 participants, below the 2,393-participant average among 105 other Crohn's Disease trials with a reported enrollment target (91% lower). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02084290, a NA study of Crohn's Disease, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 14
- Study locations
Study Summary
Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatments are right for them and will lead to a higher acceptance of appropriate therapy, improved persistence with chosen therapy, lower costs and improved clinical outcomes. To accomplish this aim, Investigators will perform a randomized controlled trial to: 1. Determine how the shared decision making program influences patients' choice of therapy 2. Evaluate how the shared decision making program affects persistence with chosen therapy 3. Determine how the shared decision making program affects decision quality 4. Determine how the shared decision making program influences cost of care and clinical outcomes Expected Outcome and Impact: Investigators expect that this program will influence patients' choice of therapy, persistence with their preferred therapy, and lead to improved clinical outcomes. Investigators believe that this product can be successfully operationalized in the clinic to establish a new paradigm of how providers can communicate personalized treatment options to patients across a broad range of diseases.
Conditions Studied
Interventions
- BEHAVIORAL Shared Decision Making Program
Study Locations (14)
New York
- Long Island Clinical Research Associates, LLP - Great Neck
- Winthrop University Hospital - Mineola
- Mount Sinai Medical Center - New York
Pennsylvania
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
California
- Cedars-Sinai Medical Center - Los Angeles
Georgia
- Atlanta Gastroenterology Associates - Atlanta
Illinois
- University of Chicago - Chicago
Maryland
- University of Maryland Medical Center - Baltimore
Massachusetts
- Brigham and Women's Hospital - Chestnut Hill
Minnesota
- Minnesota Gastroenterology - Plymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT02084290 record still lists
NCT02084290 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 2,393-participant average among 105 other Crohn's Disease trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision Making Program is the first listed.
NCT02084290 lists 14 locations in 11 states (New York, Pennsylvania, California).
Frequently Asked Questions
What is clinical trial NCT02084290 about?
NCT02084290 is a clinical study titled "Evaluating a Shared Decision Making Program for Crohn's Disease". Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatm...
What is the current status of trial NCT02084290?
This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2014-03. Estimated completion is 2018-12-31.
What conditions does trial NCT02084290 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT02084290?
The interventions under investigation include: Shared Decision Making Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02084290?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02084290 being conducted?
This trial has 14 study locations across California, Georgia, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02084290's enrollment target sits among peer trials
204 51st of 105 higher than 55 of 105 other Crohn's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
RECRUITING · NA
-
Behavioral Therapy for Crohn's Disease
RECRUITING · NA
-
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
RECRUITING · NA
-
Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
ACTIVE NOT RECRUITING · NA
-
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
COMPLETED · NA
-
Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia